Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the ...

Replimune Group, Inc – a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies – ...

As usual, the one-two punch of ASCO and BIO set us a bit behind, but never fear – your June hires round-up is here at least ...

In a post-ASCO 2025 conversation, pharmaphorum web editor Nicole Raleigh spoke with Dr Pamela Tenaerts, chief medical officer at Medable, about the company’s new digital-first model to handle ...

Nevertheless, there are issues here, too, with long waiting lists, resource constraints, and patient strife when attempting to access treatments and consultations. There are even problems with rising ...